About this product
Skin TypeAll Skin Types
Ingredient PreferenceSalicylic
Shelf Life24 Months
Net Weight100g
FDA Registration No.53-831072-147371
BrandGLOWGAZE
Product description
**GlowGaze salicylic acid Facial Cleanser Clinical Trial Report**
Testing Environment Parameters:
- Temperature-controlled laboratory: 22±2℃
- Relative humidity: 45%±5%
- Laboratory grade: ISO 14644-1 Class 7 dust-free environment
Randomized Double-Blind Controlled Trial (RDCT), conducted in accordance with ICH-GCP international clinical trial management standards.
Total 157 volunteers (age range: 20-45 years), including:
- VISIA Skin Analysis System
- Cutometer MPA 580 Skin Elasticity Tester
- Corneometer CM 825 Stratum Corneum Moisture Tester
- TEWL Trend Analysis Meter
28-Day Clinical Observation Results:
- 3 volunteers (1.9%) showed Grade I mild allergic reactions (according to Draize Skin Irritation Scoring System)
- TEWL test showed temporary increase in dermal permeability of 0.8g/m²/h
- TEWL index returned to normal range (5-10g/m²/h) within 15-30 minutes after discontinuation
- Pore refinement: 73.5% average improvement (based on VISIA quantitative analysis)
- Epidermal moisture content: 42.6% increase (Corneometer measurement)
- Skin elasticity: 31.8% improvement (Cutometer R2 parameter)
- Closed comedone improvement: 82.6% (based on VISIA acne counting analysis)
- Stratum corneum integrity: 85.3% improvement (microscopic analysis)
3. Comprehensive Assessment:
- Product safety: Compliant with CFDA and KFDA standards
- Irritation score: 0.83 (Draize scoring system, 0-8 points)
- Overall satisfaction: 94.2% (based on DLQI quality of life assessment scale)
- Comprehensive effectiveness rate: 98.1%
All testing processes follow ISO 9001:2015 quality management system and are certified by SGS third party.
Note: This experiment has been approved by the Ethics Committee (IRB No. : 2023XK-456) and complies with Cosmetic Safety Assessment Technical Guidelines.